Methodological issues in evaluating measures of health as outcomes for COPD

被引:103
作者
Jones, PW [1 ]
Kaplan, RM
机构
[1] St George Hosp, Sch Med, London SW17 0RE, England
[2] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA
关键词
chronic obstructive pulmonary disease; health status; measurement standardisation; outcome measures; utility-based measures;
D O I
10.1183/09031936.03.00077803
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The selection of an appropriate outcome measure depends on the aspect of the disease being addressed and the purpose of the study being conducted. The most fundamental property of any outcome is its ability to measure the biological variable under question. Other properties such as discriminative and evaluative abilities are also important. Specific outcomes measure a single biological variable, such as forced expiratory volume in one second or depression. The specificity of such measures is attractive but what is being measured and why. Other, summative, requires precise definition of. outcomes are used to quantify the overall effect of a number of different biological processes. The simplest summative measures are global questions such as "How would you rate your health overall?" Others are complex with many items. If designed and used correctly, these questionnaires can provide an estimate of the overall impact of disease or response to therapy and an index of whether that response was clinically worthwhile. Standardisation of measurements is important to permit comparisons between patients and studies, which makes the measurement of an individual's "quality of life" difficult. The term "health-status measurement" may, be better when referring to the use of standardised questionnaires. Utility-based measures help address concerns regarding clinical versus statistical improvement and place outcomes for chronic obstructive pulmonary. disease treatment trials in the context of all healthcare treatments.
引用
收藏
页码:13S / 18S
页数:6
相关论文
共 62 条
  • [11] RELIABILITY AND VALIDITY OF DYSPNEA MEASURES IN PATIENTS WITH OBSTRUCTIVE LUNG-DISEASE
    EAKIN, EG
    SASSIDAMBRON, DE
    RIES, AL
    KAPLAN, RM
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 1995, 2 (02) : 118 - 134
  • [12] MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX
    FEENY, D
    FURLONG, W
    BOYLE, M
    TORRANCE, GW
    [J]. PHARMACOECONOMICS, 1995, 7 (06) : 490 - 502
  • [13] Feeny D, 1999, INT J CANCER, P2
  • [14] GODL MR, 1996, COST EFFECTIVENESS H
  • [15] Health state valuations from the general public using the Visual Analogue Scale
    Gudex, C
    Dolan, P
    Kind, P
    Williams, A
    [J]. QUALITY OF LIFE RESEARCH, 1996, 5 (06) : 521 - 531
  • [16] THE ROLE OF BEFORE AFTER STUDIES OF THERAPEUTIC IMPACT IN THE EVALUATION OF DIAGNOSTIC TECHNOLOGIES
    GUYATT, GH
    TUGWELL, PX
    FEENY, DH
    DRUMMOND, MF
    HAYNES, RB
    [J]. JOURNAL OF CHRONIC DISEASES, 1986, 39 (04): : 295 - 304
  • [17] Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation
    Guyatt, GH
    King, DR
    Feeny, DH
    Stubbing, D
    Goldstein, RS
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (03) : 187 - 192
  • [18] A MEASURE OF QUALITY-OF-LIFE FOR CLINICAL-TRIALS IN CHRONIC LUNG-DISEASE
    GUYATT, GH
    BERMAN, LB
    TOWNSEND, M
    PUGSLEY, SO
    CHAMBERS, LW
    [J]. THORAX, 1987, 42 (10) : 773 - 778
  • [19] RESPONSIVENESS AND VALIDITY IN HEALTH-STATUS MEASUREMENT - A CLARIFICATION
    GUYATT, GH
    DEYO, RA
    CHARLSON, M
    LEVINE, MN
    MITCHELL, A
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (05) : 403 - 408
  • [20] The concept of clinically meaningful difference in health-related quality-of-life research - How meaningful is it?
    Hays, RD
    Woolley, JM
    [J]. PHARMACOECONOMICS, 2000, 18 (05) : 419 - 423